134 related articles for article (PubMed ID: 16113408)
1. The cystic fibrosis transmembrane regulator forms macromolecular complexes with PDZ domain scaffold proteins.
Guggino WB
Proc Am Thorac Soc; 2004; 1(1):28-32. PubMed ID: 16113408
[TBL] [Abstract][Full Text] [Related]
2. Endocytic trafficking of CFTR in health and disease.
Ameen N; Silvis M; Bradbury NA
J Cyst Fibros; 2007 Jan; 6(1):1-14. PubMed ID: 17098482
[TBL] [Abstract][Full Text] [Related]
3. Yes-associated protein 65 localizes p62(c-Yes) to the apical compartment of airway epithelia by association with EBP50.
Mohler PJ; Kreda SM; Boucher RC; Sudol M; Stutts MJ; Milgram SL
J Cell Biol; 1999 Nov; 147(4):879-90. PubMed ID: 10562288
[TBL] [Abstract][Full Text] [Related]
4. Nicotine Induces Progressive Properties of Lung Adenocarcinoma A549 Cells by Inhibiting Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Expression and Plasma Membrane Localization.
Li H; Ma N; Wang J; Wang Y; Yuan C; Wu J; Luo M; Yang J; Chen J; Shi J; Liu X
Technol Cancer Res Treat; 2018 Jan; 17():1533033818809984. PubMed ID: 30384810
[TBL] [Abstract][Full Text] [Related]
5. A macromolecular complex of beta 2 adrenergic receptor, CFTR, and ezrin/radixin/moesin-binding phosphoprotein 50 is regulated by PKA.
Naren AP; Cobb B; Li C; Roy K; Nelson D; Heda GD; Liao J; Kirk KL; Sorscher EJ; Hanrahan J; Clancy JP
Proc Natl Acad Sci U S A; 2003 Jan; 100(1):342-6. PubMed ID: 12502786
[TBL] [Abstract][Full Text] [Related]
6. CRISPR/Cas9 bioluminescence-based assay for monitoring CFTR trafficking to the plasma membrane.
Ondra M; Lenart L; Centorame A; Dumut DC; He A; Zaidi SSZ; Hanrahan JW; De Sanctis JB; Radzioch D; Hajduch M
Life Sci Alliance; 2024 Jan; 7(1):. PubMed ID: 37918963
[TBL] [Abstract][Full Text] [Related]
7. Crystallization and preliminary diffraction analysis of the CAL PDZ domain in complex with a selective peptide inhibitor.
Amacher JF; Cushing PR; Weiner JA; Madden DR
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2011 May; 67(Pt 5):600-3. PubMed ID: 21543871
[TBL] [Abstract][Full Text] [Related]
8. A stabilizing influence: CAL PDZ inhibition extends the half-life of ΔF508-CFTR.
Cushing PR; Vouilleme L; Pellegrini M; Boisguerin P; Madden DR
Angew Chem Int Ed Engl; 2010 Dec; 49(51):9907-11. PubMed ID: 21105033
[No Abstract] [Full Text] [Related]
9. Intracellular Delivery of Peptidyl Ligands by Reversible Cyclization: Discovery of a PDZ Domain Inhibitor that Rescues CFTR Activity.
Qian Z; Xu X; Amacher JF; Madden DR; Cormet-Boyaka E; Pei D
Angew Chem Int Ed Engl; 2015 May; 54(20):5874-8. PubMed ID: 25785567
[TBL] [Abstract][Full Text] [Related]
10. Cystic fibrosis mice rehabilitated for studies of airway gland dysfunction.
de Jonge HR
J Physiol; 2007 Apr; 580(Pt 1):7-8. PubMed ID: 17317740
[No Abstract] [Full Text] [Related]
11. Saccharomyces cerivisiae as a model system for kidney disease: what can yeast tell us about renal function?
Kolb AR; Buck TM; Brodsky JL
Am J Physiol Renal Physiol; 2011 Jul; 301(1):F1-11. PubMed ID: 21490136
[TBL] [Abstract][Full Text] [Related]
12. Pore-forming small molecules offer a promising way to tackle cystic fibrosis.
Sheppard DN; Davis AP
Nature; 2019 Mar; 567(7748):315-317. PubMed ID: 30880331
[No Abstract] [Full Text] [Related]
13. A
Staab-Weijnitz CA
Am J Respir Cell Mol Biol; 2024 Mar; 70(3):155-156. PubMed ID: 38060429
[No Abstract] [Full Text] [Related]
14. Hormonal regulation of non-cystic fibrosis transmembrane conductance regulator ion channels in the endocervix.
Roberts M; Yao S; Wei S; Jensen JT; Han L
F S Sci; 2023 May; 4(2):163-171. PubMed ID: 36907435
[TBL] [Abstract][Full Text] [Related]
15. Microtubule-Associated Serine/Threonine (MAST) Kinases in Development and Disease.
Rumpf M; Pautz S; Drebes B; Herberg FW; Müller HJ
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569286
[TBL] [Abstract][Full Text] [Related]
16. Expression of CFTR, a hallmark gene of ionocytes, is downregulated in salivary glands of Sjögren's syndrome patients.
Zhang Q; Lv X; Wang Y; Wang B; He Y; Chen C; Shi G; Li Y
Arthritis Res Ther; 2022 Dec; 24(1):263. PubMed ID: 36476557
[TBL] [Abstract][Full Text] [Related]
17. CyFi-MAP: an interactive pathway-based resource for cystic fibrosis.
Pereira C; Mazein A; Farinha CM; Gray MA; Kunzelmann K; Ostaszewski M; Balaur I; Amaral MD; Falcao AO
Sci Rep; 2021 Nov; 11(1):22223. PubMed ID: 34782688
[TBL] [Abstract][Full Text] [Related]
18. Targeting PDZ domains as potential treatment for viral infections, neurodegeneration and cancer.
Nardella C; Visconti L; Malagrinò F; Pagano L; Bufano M; Nalli M; Coluccia A; La Regina G; Silvestri R; Gianni S; Toto A
Biol Direct; 2021 Oct; 16(1):15. PubMed ID: 34641953
[TBL] [Abstract][Full Text] [Related]
19. Pathobiology of inherited biliary diseases: a roadmap to understand acquired liver diseases.
Fabris L; Fiorotto R; Spirli C; Cadamuro M; Mariotti V; Perugorria MJ; Banales JM; Strazzabosco M
Nat Rev Gastroenterol Hepatol; 2019 Aug; 16(8):497-511. PubMed ID: 31165788
[TBL] [Abstract][Full Text] [Related]
20. Pathophysiology of Cystic Fibrosis Liver Disease: A Channelopathy Leading to Alterations in Innate Immunity and in Microbiota.
Fiorotto R; Strazzabosco M
Cell Mol Gastroenterol Hepatol; 2019; 8(2):197-207. PubMed ID: 31075352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
